Generics

Generic Carnitor is used for the treatment of primary systemic carnitine deficiency.

Yaral Pharma will begin commercializing the first product from IBSA’s corporate pipeline of authorized generics in January 2023.

The additional indication is for the initial treatment of patients with metastatic, non-squamous, non-small cell lung cancer with no EGFR or ALK genomic tumor aberrations.

Fresenius Kabi's lacosamide injection for intravenous use is indicated for the treatment of partial-onset seizures in patients aged 17 years old and older.

Lacosamide injection is indicated for the treatment of partial-onset seizures in patients aged 17 years old and older.

Fresenius Kabi plans to launch Idacio in a self-administered prefilled syringe and a self-administered pre-filled pen in July 2023.

CMS proposes that issuers of standardized plan options must place all covered generic drugs in the standardized plan options’ generic drug cost-sharing tier.

Levothyroxine sodium is an important medicine used in hospitals for the treatment of myxedema coma.